Figure 2
From: Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer
Molecular Docking studies: (a) Peptide 2 docked in the active site of hDHFR, pink dotted lines are H-bonds. (Non-polar Hs’ are deleted for clarity); (b) 2D diagram of the binding pose of peptide 2 in the active site of hDHFR.
